Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. medmico

MEDMICO

Moving to Efficient Diabetes care: Multimode Integrated CO-morbidity diagnostics platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MEDMICO project word cloud

Explore the words cloud of the MEDMICO project. It provides you a very rough idea of what is the project "MEDMICO" about.

months    diabetic    population    healthcare    outpatient    projections    sub    primary    epidemic    delivering    regulatory    dublin    shift    cell    diagnostics    breakthrough    provides    disruptive    clinics    combat    radisens    complications    shelf    away    ischemic    pilot    validation    vitro    gt    college    care    morbid    contractor    spearhead    trl8    prototype    evidenced    outcomes    sensitivity    submission    laboratories    2013    renal    validated    date    kidney    storage    extensive    clinical    mode    pipette    1st    life    positioning    workflow    innovation    adult    drive    room    pharmacies    patients    accuracy    incorporates    launch    multiple    screen    forefront    trinity    quad    point    comorbidities    efficient    near    immunoassays    monitor    medmico    lab    turbidimetry    poct    tests    abnormalities    panels    diabetes    12    co    cardiovascular    central    integrating    trials    biomaterials    creatinine    diagnostic    comorbid    efficiencies    counting    lipids    rising    usability    precision    ready    heart    temperature    segments    diagnose    platform    2035    single    5    incumbent    hba1c    expertise    disease    chemistry    majority    revenues    optimal    3    comorbidity    patient   

Project "MEDMICO" data sheet

The following table provides information about the project.

Coordinator		 RADISENS DIAGNOSTICS LIMITED 

Organization address
address: UNITS 1-3 WESTPOINT BUILDINGS LINK ROAD BALLINCOLL
city: CORK
postcode: IP31 HF29
website: www.radisens.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://www.radisens.com/
 Total cost 4˙487˙525 €
 EC max contribution 4˙487˙525 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-2-2014
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2018-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RADISENS DIAGNOSTICS LIMITED IE (CORK) coordinator 4˙487˙525.00

Map

 Project objective

Diabetes affects 8.5% (2013) of the adult European population rising to 10.3% (2035) and is associated with co-morbid conditions such as cardiovascular and renal abnormalities. These lead to diabetic complications, ischemic heart disease, heart failure and kidney failure. Management of this growing epidemic requires a shift in care management and delivery, away from lab testing. The majority of current diagnostic testing for diabetes and comorbidities involves central laboratories as incumbent in-vitro diagnostic point-of-care testing (PoCT) provides sub-optimal accuracy and single tests (rather than needed panels) for diabetes and its comorbidities. MEDMICO will spearhead a diagnostic breakthrough by delivering the 1st quad-mode PoCT platform integrating immunoassays, turbidimetry, clinical chemistry and cell counting. HbA1c, Lipids and Creatinine tests will be integrated on to a single diabetes comorbid platform with state-of-the-art sensitivity/precision, room temperature storage, >12 months’ shelf-life and integrated pipette to screen, diagnose and monitor patients, within primary care, outpatient clinics and pharmacies. This will improve patient outcomes and healthcare efficiencies, positioning Europe at the forefront of healthcare innovation and deliver an efficient platform to combat this epidemic. MEDMICO incorporates extensive technical, clinical and exploitation expertise - Radisens’ disruptive PoCT prototype and Trinity College Dublin (sub-contractor) biomaterials expertise and diabetes patient access. MEDMICO’s potential is evidenced by Radisens’ revenues to date and large near-term projections from diagnostics partners before its launch. Existing research of end-user needs and workflow assessment will drive platform development and pilot production, with clinical validation and usability trials in multiple PoCT segments to TRL8. This will deliver a validated quad-mode diabetes comorbidity platform, ready for regulatory submission.

 Deliverables

List of deliverables.
Target stakeholder web site & project presentation Websites, patent fillings, videos etc. 2019-07-24 15:31:59

Take a look to the deliverables list in detail:  detailed list of MEDMICO deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDMICO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDMICO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More